How Veterans are Helping Marijuana PTSD Research
By NIKKI WENTLING | STARS AND STRIPES Published: June 1, 2017
PHOENIX — The waiting room at the Scottsdale Research Institute in Arizona could be any doctor’s office, except for the faint smell of marijuana.
The scent is the only indication that the small space, inside a nondescript gray building in an industrial park on Phoenix’s northern border, is home to a groundbreaking scientific study that could have far-reaching effects.
First Marijuana Testing for Vets with PTSD Underway in Phoenix; Volunteers Wanted
By Ray Stern | Phoenix New Times Friday, February 10, 2017 at 3:30 p.m.
The first-ever clinical study of smoked cannabis for veterans with post-traumatic stress disorder took place in Phoenix this week, making medical-marijuana history.
The California-based Multidisciplinary Association for Psychedelic Studies (MAPS), founded in 1986, is conducting the study with the help of a $2.16 million grant from the Colorado Department of Public Health and Environment.
Clinical Trial Using Marijuana to Treat PTSD in Veterans Gets Underway
By: Kathleen Curthoys | Army Times February 7
The first participant in a clinical trial designed to evaluate the effectiveness of smoking marijuana to treat PTSD in veterans was given cannabis on Monday, according to the organization conducting the study.
The study will look at the safety and effectiveness of four separate levels of marijuana potency in 76 veterans. It will provide data on marijuana dosing, composition and side effects, and the potential benefits of using pot to treat PTSD.
Notice of Information Updates
Please note that although Johns Hopkins University is mentioned in several of these articles, JHU is no longer participating in this study, and should not be contacted with regards to the study.